UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 10.714

Sortiert nach

CP-094 Romiplostim dose escalation in immune thrombocytopenia patients

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A41-A42

2017

Volltextzugriff (PDF)

CP-207 Analysis of frequency of underdosing in obese patients treated with vancomycin

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A92-A93

2017

Volltextzugriff (PDF)

CP-179 Patients exceeding doxorubicin recommended cumulative dose

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A79-A79

2016

Volltextzugriff (PDF)

CP-083 Persistence of firstline biological agents among psoriasis patients

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A36-A37

2016

Volltextzugriff (PDF)

Severe malaria in immigrant haematological patient

IDCases, 2015-01, Vol.2 (3), p.77-79

2015

Volltextzugriff (PDF)

CP-187 Knowledge of HIV infected patients on antiretroviral therapy and HIV infection

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A82-A83

2016

Volltextzugriff (PDF)

CP-087 Persistence of intramuscular versus subcutaneous firstline therapies in multiple sclerosis patients

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A38-A39

2017

Volltextzugriff (PDF)

CP-215 Valproic acid intoxication and clinical utility of normalised serum valproic acid concentration in hypoalbuminaemic critically ill patients

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A96-A96

2017

Volltextzugriff (PDF)

CP-108 Adherence to parenteral firstline disease modifying therapy for multiple sclerosis

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A48-A48

2017

Volltextzugriff (PDF)

4CPS-279 Cancer pain management approach considering potential drug interactions in patients receiving oral antitumour treatment

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A54-A54

2021

Volltextzugriff (PDF)

5PSQ-118 Patients’ experience with subcutaneous injection self-administration and the role of virtual reality

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A151-A151

2023

Volltextzugriff (PDF)

4CPS-175 Sepsis code: improving outcomes for patients with sepsis

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A80-A80

2023

Volltextzugriff (PDF)

MON-PO496: Hepatobiliary Complications of Total Parenteral Nutrition Management with Taurine Enriched Aminoacid Solutions

Clinical nutrition (Edinburgh, Scotland), 2019-09, Vol.38, p.S242-S242

2019

Volltextzugriff (PDF)

4CPS-160 Real-world persistence with dolutegravir/lamivudine versus bictegravir/emtricitabina/tenofovir alafenamide among human immunodeficiency virus patients

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A75-A75

2023

Volltextzugriff (PDF)

Stability of carboplatin infusion solutions used in desensitization protocol

Journal of oncology pharmacy practice, 2019-07, Vol.25 (5), p.1076-1081

2019

Volltextzugriff (PDF)

4CPS-082 Risk of myelotoxicity in non-cancer patients treated with chemotherapy

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A85-A86

2020

Volltextzugriff (PDF)

4CPS-078 Effectiveness and safety of eribulin for advanced breast cancer treatment

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A83-A84

2020

Volltextzugriff (PDF)

4CPS-069 Evaluation of palivizumab as prophylaxis against respiratory syncytial virus infection

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A79-A80

2020

Volltextzugriff (PDF)

CP-122 First cycle neutropenia and relative dose intensity in localised breast cancer patients treated with an adjuvant AC protocol followed by weekly paclitaxel

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A53-A54

2016

Volltextzugriff (PDF)

4CPS-237 Hyperkalaemia and risk factors: screening and assessment in hospital patients

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A102-A102

2023

Volltextzugriff (PDF)

5PSQ-061 Stability of carboplatin infusion solutions used in desensitisation protocol

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A192-A194

2018

Volltextzugriff (PDF)

4CPS-126 Real-world persistence with fampridine among multiple sclerosis patients

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A187-A188

2022

Volltextzugriff (PDF)

4CPS-235 Parenteral nutrition-associated cholestasis as an early-onset adverse effect in adult patients

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A178-A179

2019

Volltextzugriff (PDF)

4CPS-035 Clinical pharmacokinetics of vancomycin in neutropenic patients

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A63-A64

2020

Volltextzugriff (PDF)

4CPS-234 Glucocorticoid induced hyperglycaemia in non-diabetic patients in an emergency department

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A32-A32

2021

Volltextzugriff (PDF)

1 – 25 von 10.714

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.864)
Mit Volltextzugriff
(9.769)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.326)
Life Sciences & Biomedicine
(4.256)
Humans
(2.673)
Female
(1.643)
Male
(1.616)
Technology
(1.560)
Physical Sciences
(1.143)
Middle Aged
(980)
Adult
(906)
Aged
(803)
Engineering
(735)
Computer Science
(661)
Chemistry
(610)
Biological And Medical Sciences
(607)
Animals
(482)
Spain
(455)
Engineering, Electrical & Electronic
(421)
Risk Factors
(404)
Adolescent
(379)
Patients
(366)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CP-094 Romiplostim dose escalation in immune thrombocytopenia patients

CP-207 Analysis of frequency of underdosing in obese patients treated with vancomycin

CP-179 Patients exceeding doxorubicin recommended cumulative dose

CP-083 Persistence of firstline biological agents among psoriasis patients

Severe malaria in immigrant haematological patient

CP-187 Knowledge of HIV infected patients on antiretroviral therapy and HIV infection

CP-087 Persistence of intramuscular versus subcutaneous firstline therapies in multiple sclerosis patients

CP-215 Valproic acid intoxication and clinical utility of normalised serum valproic acid concentration in hypoalbuminaemic critically ill patients

CP-108 Adherence to parenteral firstline disease modifying therapy for multiple sclerosis

4CPS-279 Cancer pain management approach considering potential drug interactions in patients receiving oral antitumour treatment

5PSQ-118 Patients’ experience with subcutaneous injection self-administration and the role of virtual reality

4CPS-175 Sepsis code: improving outcomes for patients with sepsis

MON-PO496: Hepatobiliary Complications of Total Parenteral Nutrition Management with Taurine Enriched Aminoacid Solutions

4CPS-160 Real-world persistence with dolutegravir/lamivudine versus bictegravir/emtricitabina/tenofovir alafenamide among human immunodeficiency virus patients

Stability of carboplatin infusion solutions used in desensitization protocol

4CPS-082 Risk of myelotoxicity in non-cancer patients treated with chemotherapy

4CPS-078 Effectiveness and safety of eribulin for advanced breast cancer treatment

4CPS-069 Evaluation of palivizumab as prophylaxis against respiratory syncytial virus infection

CP-122 First cycle neutropenia and relative dose intensity in localised breast cancer patients treated with an adjuvant AC protocol followed by weekly paclitaxel

4CPS-237 Hyperkalaemia and risk factors: screening and assessment in hospital patients

5PSQ-061 Stability of carboplatin infusion solutions used in desensitisation protocol

4CPS-126 Real-world persistence with fampridine among multiple sclerosis patients

4CPS-235 Parenteral nutrition-associated cholestasis as an early-onset adverse effect in adult patients

4CPS-035 Clinical pharmacokinetics of vancomycin in neutropenic patients

4CPS-234 Glucocorticoid induced hyperglycaemia in non-diabetic patients in an emergency department

Suchergebnisse filtern